History

2005 - TetraQ established by four founders (Professors Maree Smith, Ron Dickinson, Istvan Toth and Rod Minchin of The University of Queensland) who collectively had >100 years experience in life sciences R&D commercialization

2005 - ISO17025 accreditation (NATA)

2007 - GLP recognition (NATA)

2008 - Preclinical Drug Development seminar series launched in collaboration with the regulatory consultancy GZP Inc., USA

2009 - USA presence established: appointment of Mr Kris Dyszynski as VP Business Development North-America

2009 - Strategic partnership with MORE Medical Inc., Japan, and the Phase I/II clinical CRO, Q-Pharm Pty Limited, Australia

2010 - Passed 400 projects mark: clients from USA, Japan, Europe, Australia, New Zealand, Malaysia

2011 - European presence established: strategic partnership with Clinical Reach Drug Development, The Netherlands
 
2011 - ISO17025 accreditation and GLP recognition maintained following the bi-annual audits by NATA

2011 - Collaboration and co-marketing with the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Germany